13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q3 2017. See the latest, Q2 2026 →
Reported value
$435.63B
+2.6% on the quarter before
Positions
2,190
233 new · 232 sold out
Top 10
14.2%
of the value
Est. gain
+$13.43B
on stocks held all quarter
Est. return
+3.4%
on those stocks since Q2 2017
Positions as of Sep 30, 2017, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 26% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2017. Striped tiles are options.
Largest buys
Since Q2 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Dowdupont Inc~$2.38BNew · 0.0% → 0.5%+34,312,449 shares
- Verizon Communications Inc~$1.72BAdded · 0.5% → 0.9%+34,805,632 shares
- Alphabet~$953.2MAdded · 0.4% → 0.6%+993,787 shares
- Knight Swift Transn Hldgs In~$868.6MNew · 0.0% → 0.2%+20,905,344 shares
- Starbucks Corp~$655.0MAdded · 0.0% → 0.2%+12,195,723 shares
- Medtronic Plc~$600.2MAdded · 1.2% → 1.2%+7,717,991 shares
- Metlife Inc~$530.2MAdded · 0.6% → 0.6%+10,206,179 shares
- Kinder Morgan~$499.2MAdded · 0.3% → 0.4%+26,029,639 shares
- Thermo Fisher Scientific Inc~$432.5MAdded · 0.3% → 0.4%+2,285,984 shares
- Netapp Inc~$425.1MAdded · 0.0% → 0.1%+9,714,758 shares
Largest sells
Since Q2 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Dow Chem Co~$2.31BSold out · 0.5% → 0.0%−36,603,331 shares
- Wells Fargo Co New~$1.77BCut · 1.2% → 0.7%−32,042,455 shares
- Lowes Cos Inc~$1.18BCut · 0.4% → 0.1%−14,716,984 shares
- Apple~$1.11BCut · 1.2% → 1.0%−7,176,609 shares
- Automatic Data Processing~$766.3MCut · 0.3% → 0.1%−7,010,110 shares
- Amazon~$673.9MCut · 0.4% → 0.2%−700,947 shares
- Canadian Natl Ry Co~$656.8MCut · 0.6% → 0.4%−7,943,747 shares
- Alibaba~$537.7MCut · 0.6% → 0.5%−3,113,539 shares
- Lockheed Martin Corp~$526.1MCut · 0.6% → 0.6%−1,695,381 shares
- Chubb Limited~$506.7MCut · 1.1% → 0.9%−3,554,701 shares
Holdings
As of Sep 30, 2017. Changes are in shares against Jun 30, 2017, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb CoCOM · shares −2.2% · price +14.4% | 2.2% | $9.41B | +$1.18B | ||||||||
| MicrosoftCOM · shares −4.7% · price +8.1% | 1.9% | $8.47B | +$632.4M | ||||||||
| Unitedhealth Group IncCOM · shares −4.5% · price +5.6% | 1.6% | $6.90B | +$367.2M | ||||||||
| Merck & Co IncCOM · shares −1.4% · price −0.1% | 1.6% | $6.76B | −$6.3M | ||||||||
| Jpmorgan Chase & CoCOM · shares −2.9% · price +4.5% | 1.3% | $5.65B | +$243.2M | ||||||||
| Eli LillyCOM · shares +5.6% · price +3.9% | 1.2% | $5.21B | +$187.0M | ||||||||
| Medtronic PlcSHS · shares +13% · price −12.4% | 1.2% | $5.11B | −$636.5M | ||||||||
| Chevron Corp NewCOM · shares +0.2% · price +12.6% | 1.1% | $4.91B | +$548.8M | ||||||||
| Pnc Finl Svcs Group IncCOM · shares −3.3% · price +7.9% | 1.1% | $4.79B | +$351.9M | ||||||||
| Bank Amer CorpCOM · shares −7.3% · price +4.5% | 1.0% | $4.50B | +$191.9M | ||||||||
| AppleCOM · shares −20% · price +7.0% | 1.0% | $4.37B | +$286.1M | ||||||||
| Chubb LimitedCOM · shares −11% · price −1.9% | 0.93% | $4.05B | −$80.4M | ||||||||
| Allergan PlcSHS · shares −5.2% · price −15.7% | 0.92% | $4.02B | −$748.2M | ||||||||
| Johnson & JohnsonCOM · shares −5.9% · price −1.7% | 0.92% | $4.00B | −$70.2M | ||||||||
| Exxon Mobil CorpCOM · shares −0.4% · price +1.5% | 0.90% | $3.93B | +$60.0M | ||||||||
| Verizon Communications IncCOM · shares +79% · price +10.8% | 0.89% | $3.90B | +$212.4M | ||||||||
| IntelCOM · shares −7.2% · price +12.9% | 0.89% | $3.88B | +$441.9M | ||||||||
| MetaCL A · shares +1.1% · price +13.2% | 0.84% | $3.65B | +$420.3M | ||||||||
| Mckesson CorpCOM · shares +5.0% · price −6.6% | 0.83% | $3.61B | −$244.9M | ||||||||
| United Parcel Service IncCL B · shares +1.5% · price +8.6% | 0.81% | $3.52B | +$274.4M | ||||||||
| Citigroup IncCOM NEW · shares −1.4% · price +8.8% | 0.80% | $3.50B | +$282.2M | ||||||||
| AlphabetCAP STK CL A · shares +7.7% · price +4.7% | 0.79% | $3.46B | +$145.3M | ||||||||
| Marsh & Mclennan Cos IncCOM · shares −5.9% · price +7.5% | 0.78% | $3.38B | +$235.8M | ||||||||
| BlackRockCOM · shares +0.9% · price +5.8% | 0.75% | $3.25B | +$177.5M | ||||||||
| Pepsico IncCOM · shares −2.1% · price −3.5% | 0.74% | $3.22B | −$117.3M | ||||||||
| Total · 2,190 positions | 100% | $435.63B | +$13.43B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2017 to Q3 2017: 1,860 stocks held throughout, up $13.43B (+3.4%).
- Bristol Myers Squibb Co+$1.18B+14%
- Microsoft+$632.4M+8%
- Chevron Corp New+$548.8M+13%
- Intel+$441.9M+13%
- Alibaba+$430.8M+23%
- Nike Inc−$341.3M−12%
- Teva Pharmaceutical Inds Ltd−$380.5M−47%
- Cardinal Health Inc−$454.7M−14%
- Medtronic Plc−$636.5M−12%
- Allergan Plc−$748.2M−16%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |